Joshua D. Brandstadter

Hematology

3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

CCL19+ fibroblasts define a proliferative niche in chronic lymphocytic leukemia.

CCL19+ fibroblasts define a proliferative niche in chronic lymphocytic leukemia.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

Breast-implant associated unicentric castleman disease: a case report.

Breast-implant associated unicentric castleman disease: a case report.

Journal: Current problems in cancer. Case reports

Published: March 16, 2026

Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH.

Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH.

Journal: American journal of hematology

Published: August 04, 2025

How I diagnose Castleman disease.

How I diagnose Castleman disease.

Journal: American journal of clinical pathology

Published: July 01, 2025

Fibroblastic reticular cells form reactive myeloid cell niches in human lymph nodes.

Fibroblastic reticular cells form reactive myeloid cell niches in human lymph nodes.

Journal: Science immunology

Published: May 02, 2025

Erratum to: Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.

Erratum to: Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.

Journal: Haematologica

Published: May 01, 2025

A common progenitor gives rise to fibroblastic reticular cells and vascular smooth muscle cells in murine lymph nodes.

A common progenitor gives rise to fibroblastic reticular cells and vascular smooth muscle cells in murine lymph nodes.

Journal: The Journal of experimental medicine

Published: December 04, 2024

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.

Journal: Blood advances

Published: July 30, 2024

Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination.

Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination.

Journal: Blood neoplasia

Published: July 24, 2024

Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs.

Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs.

Journal: Immunity

Published: January 09, 2024

Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.

Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.

Journal: British journal of haematology

Published: October 02, 2023

Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation.

Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation.

Journal: The Journal of experimental medicine

Published: September 27, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026